(Q40792092)

23 September 2017

1 reference

title

Renin profiling for diagnosis, risk assessment, and treatment of hypertension (English)

1 reference

23 September 2017

Laragh JH

1

1 reference

23 September 2017

language of work or name

English

0 references

publication date

1 November 1993

1 reference

23 September 2017

1 reference

23 September 2017

volume

44

1 reference

23 September 2017

issue

5

1 reference

23 September 2017

page(s)

1163-1175

1 reference

https://scigraph.springernature.com/pub.10.1038/ki.1993.363

23 September 2017

exact match

0 references

cites work

Renin, angiotensin and aldosterone system in pathogenesis and management of hypertensive vascular disease

1 reference

https://api.crossref.org/works/10.1038%2FKI.1993.363

7 January 2021

Vasoconstriction-volume analysis for understanding and treating hypertension: the use of renin and aldosterone profiles

1 reference

https://api.crossref.org/works/10.1038%2FKI.1993.363

7 January 2021

PROLONGED INFUSIONS OF ANGIOTENSIN II AND NOREPINEPHRINE AND BLOOD PRESSURE, ELECTROLYTE BALANCE, AND ALDOSTERONE AND CORTISOL SECRETION IN NORMAL MAN AND IN CIRRHOSIS WITH ASCITES.

1 reference

https://api.crossref.org/works/10.1038%2FKI.1993.363

7 January 2021

The captopril test for identifying renovascular disease in hypertensive patients

1 reference

https://api.crossref.org/works/10.1038%2FKI.1993.363

7 January 2021

VASCULAR REACTIVITY TO ANGIOTENSIN II AND NOREPINEPHRINE IN PREGNANT WOMEN

1 reference

https://api.crossref.org/works/10.1038%2FKI.1993.363

7 January 2021

Hypotensive agents and pressor substances. The effect of epinephrine, norepinephrine, angiotensin II, and others on the secretory rate of aldosterone in man

1 reference

https://api.crossref.org/works/10.1038%2FKI.1993.363

7 January 2021

The role of aldosterone in man. Evidence for regulation of electrolyte balance and arterial pressure by a renal-adrenal system which may be involved in malignant hypertension

1 reference

https://api.crossref.org/works/10.1038%2FKI.1993.363

7 January 2021

Propranolol inhibition of renin secretion. A specific approach to diagnosis and treatment of renin-dependent hypertensive diseases

1 reference

https://api.crossref.org/works/10.1038%2FKI.1993.363

7 January 2021

Estimating renin participation in hypertension: Superiority of converting enzyme inhibitor over saralasin

1 reference

https://api.crossref.org/works/10.1038%2FKI.1993.363

7 January 2021

Clinical experience with blockade of the renin-angiotensin-aldosterone system by an oral converting-enzyme inhibitor (SQ 14,225, captopril) in hypertensive patients

1 reference

https://api.crossref.org/works/10.1038%2FKI.1993.363

7 January 2021

An angiotensin converting-enzyme inhibitor to identify and treat vasoconstrictor and volume factors in hypertensive patients

1 reference

https://api.crossref.org/works/10.1038%2FKI.1993.363

7 January 2021

Clinical characteristics of hypertension associated with unilateral renal disease

1 reference

https://api.crossref.org/works/10.1038%2FKI.1993.363

7 January 2021

Prevalence of Renovascular Hypertension in Patients with Grade III or IV Hypertensive Retinopathy

1 reference

https://api.crossref.org/works/10.1038%2FKI.1993.363

7 January 2021

A role for renin in rebound hypertension and encephalopathy after infusion of saralasin acetate (Sar1-Ala8-angiotensin II)

1 reference

https://api.crossref.org/works/10.1038%2FKI.1993.363

7 January 2021

Reversal of Vascular and Renal Crises of Scleroderma by Oral Angiotensin-Converting-Enzyme Blockade

1 reference

https://api.crossref.org/works/10.1038%2FKI.1993.363

7 January 2021

Essential hypertension: renin and aldosterone, heart attack and stroke.

1 reference

https://api.crossref.org/works/10.1038%2FKI.1993.363

7 January 2021

Renin as a risk factor in essential hypertension: More evidence

1 reference

https://api.crossref.org/works/10.1038%2FKI.1993.363

7 January 2021

Low and high renin essential hypertension: a comparison of clinical and biochemical characteristics

1 reference

https://api.crossref.org/works/10.1038%2FKI.1993.363

7 January 2021

Acute renal failure, tubular necrosis, and myocardial infarction induced in the rabbit by intravenous angiotensin II.

1 reference

https://api.crossref.org/works/10.1038%2FKI.1993.363

7 January 2021

Angiotensin- and norepinephrine-induced myocardial lesions: experimental and clinical studies in rabbits and man

1 reference

https://api.crossref.org/works/10.1038%2FKI.1993.363

7 January 2021

Relation of plasma renin to end organ damage and to protection of K+ feeding in stroke-prone hypertensive rats

1 reference

https://api.crossref.org/works/10.1038%2FKI.1993.363

7 January 2021

Enalapril prevents stroke and kidney dysfunction in salt-loaded stroke-prone spontaneously hypertensive rats

1 reference

https://api.crossref.org/works/10.1038%2FKI.1993.363

7 January 2021

Association of the renin-sodium profile with the risk of myocardial infarction in patients with hypertension

1 reference

https://api.crossref.org/works/10.1038%2FKI.1993.363

7 January 2021

Issues, goals, and guidelines in selecting first-line drug therapy for hypertension

1 reference

https://api.crossref.org/works/10.1038%2FKI.1993.363

7 January 2021

Altered pressor responses in long-term nitrendipine treatment

1 reference

https://api.crossref.org/works/10.1038%2FKI.1993.363

7 January 2021

Beta blockade during and after myocardial infarction: an overview of the randomized trials

1 reference

https://api.crossref.org/works/10.1038%2FKI.1993.363

7 January 2021

Effects of enalapril on mortality in severe congestive heart failure. Results of the Cooperative North Scandinavian Enalapril Survival Study (CONSENSUS).

1 reference

https://api.crossref.org/works/10.1038%2FKI.1993.363

7 January 2021

Diltiazem and reinfarction in patients with non-Q-wave myocardial infarction. Results of a double-blind, randomized, multicenter trial

1 reference

https://api.crossref.org/works/10.1038%2FKI.1993.363

7 January 2021

Relationship of blood pressure response and the renin-angiotensin system to first-dose prazosin

1 reference

https://api.crossref.org/works/10.1038%2FKI.1993.363

7 January 2021

Some lessons from systolic hypertension in the elderly program (SHEP)

1 reference

https://api.crossref.org/works/10.1038%2FKI.1993.363

7 January 2021

Prevention of stroke by antihypertensive drug treatment in older persons with isolated systolic hypertension. Final results of the Systolic Hypertension in the Elderly Program (SHEP). SHEP Cooperative Research Group

1 reference

https://api.crossref.org/works/10.1038%2FKI.1993.363

7 January 2021

Diagnosis ex juvantibus. Individual response patterns to drugs reveal hypertension mechanisms and simplify treatment

1 reference

https://api.crossref.org/works/10.1038%2FKI.1993.363

7 January 2021

Effect of enalapril on survival in patients with reduced left ventricular ejection fractions and congestive heart failure

1 reference

https://api.crossref.org/works/10.1038%2FKI.1993.363

7 January 2021

Effect of captopril on mortality and morbidity in patients with left ventricular dysfunction after myocardial infarction. Results of the survival and ventricular enlargement trial. The SAVE Investigators

1 reference

https://api.crossref.org/works/10.1038%2FKI.1993.363

7 January 2021

Endothelin stimulated by angiotensin II augments contractility of spontaneously hypertensive rat resistance arteries

1 reference

https://api.crossref.org/works/10.1038%2FKI.1993.363

7 January 2021

Identifiers

DOI

10.1038/KI.1993.363

1 reference

Dimensions Publication ID

23 September 2017

1046053822

0 references

1 reference